Bayland Capital
Beijingpharmaron.com
Overview
Bayland Capital is a corporate venture capital arm of Pharmaron that invests in companies developing medicines, medical devices, and other medical technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CN Bio | Apr 2024 | Series B | Lead |
| Vibrant Therapeutics | Jan 2026 | Series B | Co-investor |
| PAQ Therapeutics | Jan 2026 | Series B Extension | Co-investor |
Key People
Maggie Wang
Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bayland Capital based?
Bayland Capital is headquartered in Beijing, China.
When was Bayland Capital founded?
Bayland Capital was founded in 2019.
How many portfolio companies does Bayland Capital have?
Bayland Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Bayland Capital's portfolio?
Portfolio companies visible on Caplight include CN Bio, Vibrant Therapeutics, PAQ Therapeutics.
What was Bayland Capital's most recent investment shown here?
Bayland Capital's most recent investment in this portfolio sample was in PAQ Therapeutics in 2026.
What sectors does Bayland Capital focus on?
Bayland Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Bayland Capital focus on?
Bayland Capital typically invests at the Mid stage.
See something wrong or outdated?